Vimpat and Bacteraemia - a phase IV clinical study of FDA data

Summary:

Bacteraemia is reported as a side effect among people who take Vimpat (lacosamide), especially for people who are male, 60+ old, also take Keppra, and have B-cell type acute leukaemia.

The phase IV clinical study analyzes which people have Bacteraemia when taking Vimpat. It is created by eHealthMe based on reports of 20,279 people who have side effects when taking Vimpat from the FDA, and is updated regularly.

What is Vimpat?

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 20,831 Vimpat users. Check the latest studies of Vimpat.

What is Bacteraemia?

Bacteraemia (presence of bacteria in the blood) is found to be associated with 1,029 drugs and 1,516 conditions by eHealthMe. Check the latest studies of Bacteraemia.

On Jun, 15, 2026

20,279 people reported to have side effects when taking Vimpat.
Among them, 14 people (0.07%) have Bacteraemia.

Among these 14 people:

What is the gender of people who have Bacteraemia when taking Vimpat? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Bacteraemia when taking Vimpat? *

What are other drugs people take besides Vimpat? *

What are other side effects people have besides Bacteraemia? *

Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 28.57%
Fever: 4 people, 28.57%
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 4 people, 28.57%
Altered State Of Consciousness (altered state of mind): 4 people, 28.57%
Encephalopathy (functioning of the brain is affected by some agent or condition): 3 people, 21.43%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 3 people, 21.43%
Hyperammonaemia: 3 people, 21.43%
Neutropenic Colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition): 3 people, 21.43%
Anorectal Cellulitis (serious infection that spreads under the rectal skin): 3 people, 21.43%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3 people, 21.43%

What are the existing conditions these people have? *

Gliosarcoma (a cancer of the brain that comes from glial, or supportive, brain cells): 3 people, 21.43%
B-Cell Type Acute Leukaemia (cancer of the white blood cells): 3 people, 21.43%
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 2 people, 14.29%
Lymphoma (cancer that begins in immune system cells): 2 people, 14.29%
Lambert-Eaton Syndrome (this means your immune system mistakenly targets healthy cells and tissues in the body): 2 people, 14.29%
Tuberous Sclerosis (a rare genetic disease that causes benign tumours to grow in the brain and other organs): 1 person, 7.14%
Sedation: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Vimpat and have Bacteraemia?

- Check whether Bacteraemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vimpat:

Vimpat (20,831 reports)

Bacteraemia treatments and more:

Bacteraemia (15,996 reports)

Browse all side effects of Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bacteraemia:

Bacteraemia (1,029 drugs)

Browse all the conditions that are associated with Bacteraemia:

Bacteraemia (1,516 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lacosamide (the active ingredients of Vimpat) and Vimpat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.